AIM: To identify the clinical outcomes of hepatocellular carcinoma (HCC) patients with
inconsistent α-fetoprotein (AFP) levels which were initially high and then low at recurrence …

Background The clinical value of alpha-fetoprotein (AFP) in patients with AFP-negative (< 20
ng/ml) hepatocellular carcinoma (HCC) who underwent curative resection remained …

AIM: To explore the relationship between α-fetoprotein (AFP) and various clinicopathological
variables and different staging system of hepatocellular carcinoma (HCC) thoroughly …

UICC staging) and tumor size. Although this study is retrospective, it is of interest both by the
issue raised which is still contradictory and by the large size of the cohort studied by the …

Introduction Alpha‐fetoprotein (AFP) has a valuable role in postoperative surveillance for
hepatocellular carcinoma (HCC) recurrence. The utility of pretreatment or baseline AFP …

Background The value of alpha-fetoprotein (AFP) as a prognostic indicator in patients with
hepatocellular carcinoma (HCC) has been proposed in recent studies, but the evidence so …

Abstract Background/Aim: Alpha-fetoprotein (AFP) had been used as a prognostic factor in
hepatocellular carcinoma but it was unknown what level of AFP could predict the survival of …

OBJECTIVES To assess, in a large multi-centric survey, diagnostic and prognostic reliability
of AFP, predictive factors, and any correlation with the tumor immunophenotype. METHODS …

Introduction: serum alpha-fetoprotein (AFP) was routinely employed as a tumor marker for
screening, diagnosis, and treatment follow-up of hepatocellular carcinoma (HCC). However …

The prognostic impact of serum α-fetoprotein (AFP) level in patients with hepatocellular
carcinoma (HCC) is controversial. This study aimed to investigate the predictive ability of …